Xencor Inc. (XNCR) intrinsic value & 10-year financials

Xencor Inc. (XNCR) has a Graham intrinsic value of $13.78 per share. At $22.85 on Oct 17, 2026, the stock trades 66% above that value. Over the last 10 fiscal years revenue grew 1.6% a year to $125.6M, with an average return on invested capital of -11.4%.

Graham intrinsic value
$13.78
Share price (Oct 17, 2026)
$22.85
Price vs Graham value
66% above
Market cap
$1.7B
Revenue (FY2025)
$125.6M
Revenue growth (10-yr CAGR)
1.6%
ROIC (10-yr avg)
-11.4%
Free cash flow (FY2025)
-$138.3M

XNCR 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $125.6M -$91.9M -$1.24 -$138.3M -141.4% -23.1%
FY2024 $110.5M -$232.6M -$3.58 -$208.3M -161.5% -23.7%
FY2023 $168.3M -$126.1M -$2.08 $66.7M -82.4% -19.6%
FY2022 $164.6M -$55.2M -$0.93 -$14.0M -50.1% -12.2%
FY2021 $275.1M $82.6M $1.37 -$30.2M 15.9% 8.4%
FY2020 $122.7M -$69.3M -$1.21 -$15.5M -62.6% -15.8%
FY2019 $156.7M $26.9M $0.46 $57.0M 8.8% 2.5%
FY2018 $40.6M -$70.4M -$1.31 -$87.0M -195.5% -19.8%
FY2017 $46.1M -$48.9M -$1.05 -$39.0M -116.1% -17.8%
FY2016 $109.0M $23.6M $0.56 $93.1M 20.7% 6.9%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Xencor Inc has demonstrated mature, steady growth, with revenue compounding at 1.6% annually over the past decade.

Xencor Inc has historically struggled to out-earn its cost of capital, averaging just -11.4% ROIC.

Xencor Inc has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Xencor Inc is modeled at 1.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $13.78 per share.

XNCR stock: frequently asked questions

What is the intrinsic value of Xencor Inc. (XNCR) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 1.6% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, XNCR's intrinsic value is about $13.78 per share.

Is XNCR stock undervalued?

At $22.85 (close on Oct 17, 2026), XNCR trades 66% above its Graham value of $13.78. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Xencor Inc. grown?

Revenue went from $109.0M in fiscal 2016 to $125.6M in fiscal 2025, a compound annual growth rate of 1.6%. Net income was -$91.9M in fiscal 2025.

Does Xencor Inc. generate free cash flow?

Xencor Inc. generated -$138.3M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 3 of the last 10 reported years.

What is XNCR's return on invested capital?

Average ROIC over the last 10 fiscal years was -11.4%, and average return on equity was -9.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this XNCR data come from?

From Xencor Inc.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks